Investors often lump similarcompanies from the same sector together, and as a first pass at categorizing the thousands of companies out there, thats understandable. However a closerlook under the hood of drugs giants GlaxoSmithKline (LSE: GSK)) and AstraZeneca (LSE: AZN) reveals two different strategies at play.
Our top analysts have highlightedfive top shares in theFTSE 100in our special free report “5 Shares To Retire On“. To find out the names of the shares and the reasons behind their inclusion, simplyclick hereto view it immediately with no obligations whatsoever.
Owain Bennallack has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.